Immunocore Holdings (IMCR) Treasury Shares (2025 - 2026)
Immunocore Holdings (IMCR) posted quarterly Treasury Shares of $894326.0 for Q1 2026, up 84.34% year-on-year from $485140.0 in Q1 2025, and up 80.25% on a QoQ basis from $496156.0 in Q4 2025.
Immunocore Holdings (IMCR) Treasury Shares (2025 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Treasury Shares for 2 consecutive years, with $894326.0 the latest figure, recorded in Q1 2026.
- Quarterly Treasury Shares rose 84.34% year-over-year to $894326.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $894326.0 (up 84.34% YoY) and the FY2025 annual result came in at $496156.0, changed N/A from the prior year.
- Treasury Shares rose to $894326.0 in Q1 2026 per IMCR's latest filing, from $496156.0 in the prior quarter.
- Over the last five years, Treasury Shares for IMCR reached as high as $894326.0 in Q1 2026 and fell as low as $479993.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | 894,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 894,326.00 |
| Mar 31, 2026 | 894,326.00 |
| Dec 31, 2025 | 496,156.00 |
| Dec 31, 2025 | 496,156.00 |
| Sep 30, 2025 | 491,957.00 |
| Sep 30, 2025 | 491,957.00 |
| Jun 30, 2025 | 479,993.00 |
| Jun 30, 2025 | 479,993.00 |
| Mar 31, 2025 | 485,140.00 |
| Mar 31, 2025 | 485,140.00 |